Sign In
Buy GMED
$77.95
-0.300 (-0.383%)
At Close: Jun 03, 2026
Here's Why Investors Should Retain Globus Medical (GMED) Stock
09:47am, Monday, 16'th Jan 2023
Investors are optimistic about Globus Medical's (GMED) robust performance across several international markets.
Globus Medical: An Impressive Long-Term Revenue Growth Play
07:04am, Sunday, 08'th Jan 2023
Globus Medical's long-term revenue is expected to grow at a CAGR of low double-digits driven by the company's advanced musculoskeletal solutions. The company's INR platform is its primary growth engin
Which Stocks Show Thick Skin As Bears Sink Fangs Into New Year?
08:05am, Wednesday, 04'th Jan 2023
As last year's bear market spills over into 2023, breakout index stocks like CAT, BOX, AZN and ELF stock show resilience. The post Which Stocks Show Thick Skin As Bears Sink Fangs Into New Year?
Globus Medical: Retain Buy With EPS Upside, Seeking Objectives Of $86, $106
05:46am, Friday, 18'th Nov 2022
Globus Medical is positioned to deliver tremendous EPS upside over the coming 3 quarters in our estimation. We are sizing up our long-term position with a buy at $73, confident GMED will hit this poin
Globus Medical Showing Some Reacceleration And Innovation Can Continue To Drive Growth
03:20pm, Thursday, 17'th Nov 2022
Globus showed reacceleration and share growth in the U.S. spine market in the third quarter, as technology (robotics, imaging/navigation) continues to drive implant share growth. There's room for spin
Globus Medical, Inc. (GMED) Q3 2022 Earnings Call Transcript
09:07pm, Tuesday, 08'th Nov 2022
Globus Medical, Inc. (NYSE:GMED ) Q3 2022 Earnings Conference Call November 8, 2022 4:30 PM ET Company Participants Brian Kearns - Senior Vice President, Business Development and Investor Relations Da
Globus Medical Schedules Third Quarter Earnings Release and Conference Call
04:30pm, Wednesday, 19'th Oct 2022
AUDUBON, Pa., Oct. 19, 2022 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the third quarter ended September
Here's Why Investors Should Retain Globus Medical (GMED) For Now
04:12pm, Thursday, 15'th Sep 2022
Investors are optimistic about Globus Medical's (GMED) better-than-expected results and new product introductions.
Globus Medical (GMED) Gains Market Share, Cost Woes Stay
02:17pm, Monday, 12'th Sep 2022
Globus Medical (GMED) U.S. sales increase, driven by competitive rep conversions and robotic pull-through.
Could Globus Medical Be the Best Healthcare Stock?
10:00am, Tuesday, 06'th Sep 2022
Globus Medical makes surgery faster and safer.
Globus Medical: Compelling Long-Term Value On Offer, Buy Thesis Intact
03:13pm, Friday, 02'nd Sep 2022
Globus Medical continues to offer compelling long-term value with its expertise in spinal and musculoskeletal surgery. With its entry into robotics and emerging technologies continuing to ramp up, the
Globus Medical (GMED) Q2 Earnings Beat, Gross Margin Dips
11:17am, Friday, 05'th Aug 2022
Globus Medical's (GMED) Musculoskeletal Solutions products generate solid revenues on growth in spine and trauma implant portfolios.
Globus Medical, Inc. (GMED) CEO Daniel Scavilla on Q2 2022 Results - Earnings Call Transcript
08:56pm, Thursday, 04'th Aug 2022
Globus Medical, Inc. (NYSE:GMED ) Q2 2022 Earnings Conference Call August 4, 2022 4:30 PM ET Company Participants Brian Kearns - SVP, Business Development & IR Daniel Scavilla - President, CEO & Direc
Globus Medical (GMED) Q2 Earnings and Revenues Top Estimates
08:18pm, Thursday, 04'th Aug 2022
Globus Medical (GMED) delivered earnings and revenue surprises of 3.70% and 2%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Globus Medical Schedules Second Quarter Earnings Release and Conference Call
04:30pm, Monday, 18'th Jul 2022
AUDUBON, Pa., July 18, 2022 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the second quarter ended June 30,
